These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24452752)

  • 1. Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Humphries KH; Tu JV; Behlouli H; Guo H; Pilote L
    Circulation; 2014 Mar; 129(11):1196-203. PubMed ID: 24452752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
    Lip GY; Frison L; Halperin JL; Lane DA
    J Am Coll Cardiol; 2011 Jan; 57(2):173-80. PubMed ID: 21111555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
    Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
    J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination?
    Garg L; Chen C; Haines DE
    Int J Cardiol; 2016 Nov; 222():47-50. PubMed ID: 27472258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation.
    Avgil Tsadok M; Jackevicius CA; Rahme E; Humphries KH; Behlouli H; Pilote L
    JAMA; 2012 May; 307(18):1952-8. PubMed ID: 22570463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to Dialysis.
    Sy J; Wenziger C; Marroquin M; Kalantar-Zadeh K; Kovesdy C; Streja E
    Nephron; 2022; 146(4):360-368. PubMed ID: 35124673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation.
    Avgil Tsadok M; Jackevicius CA; Rahme E; Humphries KH; Pilote L
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):593-9. PubMed ID: 26508666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
    Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
    Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Warfarin on Ischemic Stroke, Bleeding, and Mortality in Patients with Atrial Fibrillation Receiving Peritoneal Dialysis.
    Phan D; Yang SJ; Shen AY; Lee MS
    Am J Cardiovasc Drugs; 2019 Oct; 19(5):509-515. PubMed ID: 31016691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
    Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
    BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation.
    Kai B; Bogorad Y; Nguyen LN; Yang SJ; Chen W; Spencer HT; Shen AY; Lee MS
    Heart Rhythm; 2017 May; 14(5):645-651. PubMed ID: 28185918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study.
    Friberg L; Benson L; Lip GY
    Eur Heart J; 2015 Feb; 36(5):297-306. PubMed ID: 24722803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of hemodialysis patients with atrial fibrillation: The RAKUEN (Registry of atrial fibrillation in chronic kidney disease under hemodialysis from Niigata) study.
    Mitsuma W; Matsubara T; Hatada K; Imai S; Saito N; Shimada H; Miyazaki S
    J Cardiol; 2016 Aug; 68(2):148-55. PubMed ID: 26527113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Shih CJ; Ou SM; Chao PW; Kuo SC; Lee YJ; Yang CY; Tarng DC; Lin CC; Huang PH; Li SY; Chen YT
    Circulation; 2016 Jan; 133(3):265-72. PubMed ID: 26680239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.
    Fox KA; Piccini JP; Wojdyla D; Becker RC; Halperin JL; Nessel CC; Paolini JF; Hankey GJ; Mahaffey KW; Patel MR; Singer DE; Califf RM
    Eur Heart J; 2011 Oct; 32(19):2387-94. PubMed ID: 21873708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.